ABSTRACT Background: Women with polycystic ovarian syndrome (PCOS) are intrinsically insulin resistant and have a high risk of cardiovascular disease and type 2 diabetes. Weight loss improves risk factors, but the optimal diet composition is unknown. Low-glycemic index (low-GI) diets are recommended without evidence of their clinical effectiveness. Objective: We compared changes in insulin sensitivity and clinical outcomes after similar weight losses after consumption of a low-GI diet compared with a conventional healthy diet in women with PCOS. Design: We assigned overweight and obese premenopausal women with PCOS (n = 96) to consume either an ad libitum low-GI diet or a macronutrient-matched healthy diet and followed the women for 12 mo or until they achieved a 7% weight loss. We compared changes in whole-body insulin sensitivity, which we assessed using the insulin sensitivity index derived from the oral-glucose-tolerance test (ISI OGTT ); glucose tolerance; body composition; plasma lipids; reproductive hormones; health-related quality of life; and menstrual cycle regularity. Results: The attrition rate was high in both groups (49%). Among completers, ISI OGTT improved more with the low-GI diet than with the conventional healthy diet (mean 6 SEM: 2.2 6 0.7 compared with 0.7 6 0.6, respectively; P = 0.03). There was a significant dietmetformin interaction (P = 0.048), with greater improvement in ISI OGTT among women prescribed both metformin and the low-GI diet. Compared with women who consumed the conventional healthy diet, more women who consumed the low-GI diet showed improved menstrual cyclicity (95% compared with 63%, respectively; P = 0.03). Among the biochemical measures, only serum fibrinogen concentrations showed significant differences between diets (P , 0.05). Conclusion: To the best of our knowledge, this study provides the first objective evidence to justify the use of low-GI diets in the management of PCOS.
INTRODUCTION
Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women affecting 5-10% of those of childbearing age (1) . Its clinical diagnosis is based on the presence of chronic anovulation, androgen excess, and/or polycystic ovaries (2) . Common symptoms include menstrual irregularities and signs of androgen excess such as hirsutism, acne, and alopecia. PCOS is a major cause of infertility and attendant use of assisted reproductive technologies.
The majority of women with PCOS, regardless of weight, have a form of insulin resistance that is intrinsic to the syndrome (3) . Obese women with PCOS have an added burden of insulin resistance related to their adiposity. Insulin resistance results in compensatory hyperinsulinemia, which plays an important role in all the manifestations of PCOS, including androgen excess and anovulation. PCOS is also associated with a markedly increased risk of chronic disease. The prevalence of type 2 diabetes is 10 times higher among young women with PCOS than among healthy control women (4) . Impaired glucose tolerance or overt type 2 diabetes develops by the age of 30 y in 30-50% of obese women with PCOS (4) . One study estimated the risk of myocardial infarction to be .7-fold higher in women with PCOS compared with in age-matched non-PCOS women (5) . At cardiac catheterization, PCOS women show more extensive coronary lesions (6) , and even adolescent women showed significantly increased arterial stiffness than age-and body mass index (BMI)-matched control subjects (7) .
The benefits of weight reduction in individuals with PCOS are well documented (8) , although to our knowledge, the optimal diet composition has not been studied. In overweight individuals without PCOS but with high postprandial insulinemia, diets with a low glycemic load (GL) have been shown to facilitate weight reduction and weight maintenance (9) (10) (11) . Reducing postprandial insulin concentrations has been postulated to increase fat oxidation (and spare carbohydrate stores) for several hours after a meal and to reduce hunger, overeating, and weight gain (12) . Because the majority of women with PCOS show a marked compensatory hyperinsulinema after carbohydrate ingestion, there may be specific advantages of diets with a low GL in this group. Carbohydrate foods with a low glycemic index (GI) may also improve satiety and the cardiovascular outcomes of weight loss (13) . Surprisingly, to our knowledge, there are no published studies of low-GI interventions in subjects with PCOS.
In this study, our aim was to compare 2 diets of equivalent macronutrient distributions and fiber contents, in which the carbohydrate foods were either low GI or moderate-to-high GI. We hypothesized that, independent of weight loss, a low-GI diet would improve underlying insulin resistance (primary outcome) in women with PCOS and would be more effective than conventional low-fat, high-cereal fiber dietary advice in reducing the risk factors for cardiovascular disease and type 2 diabetes (secondary outcomes).
SUBJECTS AND METHODS
Women with PCOS aged 18-40 y and with a BMI [weight in kilograms divided by the height in square meters (kg/m
2 )] 25 who were without recent weight loss and were not pregnant, breastfeeding, or planning a pregnancy were eligible for study. A diagnosis of PCOS was made according to the Rotterdam criteria (14) but on the basis of self-report of a formal diagnosis by an endocrinologist or gynecologist and biochemical findings. Women who were taking the insulin-sensitizing agent metformin were eligible for the study. Exclusion criteria were the presence of diabetes or other endocrine disorders, the use of the oral contraceptive pill, antidepressants, or lipid-lowering medications, and current treatment of an eating disorder or depression. Participants were recruited locally through endocrinologists and general practitioners, newspaper articles and advertisements, and women's fitness centers. In total, 280 women were screened between September 2004 and September 2007, and 96 women met the inclusion criteria and were enrolled in the study (Figure 1) . The study was approved by the Human Research Ethics Committee of the University of Sydney and the Royal Prince Alfred Hospital Ethics Review Committee, and subjects gave written informed consent to participate in the study.
Subjects were stratified according to weight (BMI , 30 and 30) and metformin use and were consecutively assigned in strict alternate order to consume either a low-fat, low-GI diet (on the basis of low-GI breads and cereals) or a low-fat, conventional healthy diet on the basis of high-fiber and moderate-FIGURE 1. Flow of participants through the trial comparing a low-glycemic index (low GI) diet with a conventional healthy diet. PCOS, polycystic ovarian syndrome; IVF, in vitro fertilization; ITT, intention-to-treat.
to-high GI breads and cereal foods. They were instructed to follow the diets until they had lost 7% of their baseline body weight. An accredited practicing dietitian saw all participants individually to provide dietary education and follow-up throughout the study period. Participants were seen weekly to fortnightly for the first 4-6 visits and then every 2-4 wk. When face-to-face visits were not possible, follow-up was conducted by phone or e-mail.
At each visit, the weights of subjects were recorded in light clothing with electronic scales (Tanita BWB-600; Tanita Corp, Tokyo, Japan). Heights were recorded at the first visit with a wallmounted stadiometer (KaWe Kirchner & Wilhelm, Asperg, Germany). At baseline and completion of the study (after 7% weight loss was reached or after 12 mo, whichever occurred first), dual-energy X-ray absorptiometry (Lunar Prodigy; GE Health care, Giles, United Kingdom) was performed to assess changes in body composition. At the same time, fasting venous blood samples were obtained for the measurement of total cholesterol, HDL cholesterol, triglycerides, apolipoprotein B, C-reactive protein (CRP), fibrinogen, plasminogen activator inhibitor 1 (PAI-1), testosterone, sex hormone-binding globulin, luteinizing hormone, and follicle-stimulating hormone concentrations. LDL cholesterol and the free androgen index were calculated. Blood samples were analyzed at a central laboratory (Douglas Hanly Moir Pathology, Sydney, Australia). At baseline and study completion, a 2-h oral-75-g glucose-tolerance test was also performed with plasma glucose and insulin measurements performed at 0, 60, and 120 min. Whole-body insulin sensitivity was calculated by using the insulin sensitivity index derived from the oral-glucosetolerance test (ISI OGTT ) according to Matsuda and DeFronzo (10,000/square root of (fasting glucose · fasting insulin) · [mean glucose · mean insulin during OGTT]), which is highly correlated with the rate of whole-body glucose disposal during the euglyceic insulin clamp (15) . Homeostatic model assessment (HOMA) was also used to assess b cell function and insulin sensitivity. HOMA provides an estimate of the percentage b-cell function (%B) and percentage insulin sensitivity (%S) of those seen in a normal reference population, whereas the HOMA insulin resistance is the reciprocal of %S. Both the original model (HOMA1) [(fasting glucose (mmol/L) · fasting insulin (mU/L)/ 22.5] and the updated nonlinear computer model, (HOMA2) were calculated (16) . Subjects ceased using metformin 2 wk before both OGTTs to allow adequate washout.
Participants maintained a menstrual diary throughout the study to assess menstrual cyclicity. They were asked to recall their menstrual cycles in the 6 mo before commencing the study, where possible, to determine improvements or otherwise over the duration of the study. The diaries were reviewed by an independent investigator who was blinded to the subjects' dietary allocations. At baseline and study completion, the Polycystic Ovary Syndrome Questionnaire, a validated, disease-specific, health-related quality-of-life questionnaire, was used to assess changes in quality of life (17) . The questionnaire comprised 26 questions with a 7-point rating scale in 5 domains (fields): emotions, body hair, weight, infertility, and menstrual problems.
Dietary intervention
Both diets were designed as reduced-energy, low-fat, lowsaturated fat, moderate-to-high fiber diets with similar macronutrient distribution ( Table 1) . Only the quality of the carbohydrate (ie, GI) varied between the 2 diets. Diets were prescribed by using an ad libitum approach with no specific energy restriction, but participants were given a guide to portion sizes that would result in gradual weight loss with instructions based around The Australian Guide to Healthy Eating (18) . They were directed to consume unsaturated sources of fat such as nuts, seeds, avocado, and olive oil while limiting overall fat intake. A high intake of vegetables and salads was encouraged, and the intake of added sugars and alcohol was discouraged. Menu plans and shopping lists were provided, and to increase compliance, participants were provided, free of charge, a selection of key carbohydrate foods (which varied in GI value according to the diet group) every 4-6 wk. An electronic newsletter was developed and emailed to study participants each month that outlined the importance of the study and provided nutrition and exercise articles, motivational tips, and recipes (which differed according to the dietary prescription of the participants). The terms glycemic index or GI were not used during education or in any of the written material provided. Instead, diets were color coded (red or blue), and detailed instructions and shopping lists were provided that outlined the particular foods/ brands participants could choose. Participants were informed that the study was designed to compare 2 different healthy, low-fat diets that varied only in the types of carbohydrate recommended.
Participants were asked to keep a 1-wk food diary at baseline, 2-4 wk after starting the dietary intervention, and at the completion of the study. In addition, dietary compliance was checked by a dietary recall of the past 2-4-wk intake at each visit. A nutritionist entered the data into a customized database (FoodWorks Professional 2005; Xyris Software, Brisbane, Australia) to assess energy, macronutrient, and dietary fiber intakes. Commonly eaten branded foods for which nutritional data were available were added to the database. Carbohydrate-intake data were exported from the database and used to measure the dietary GI and GL. The GI of individual foods was assigned according to published values on the basis of glucose as the reference food (19) . When a published value was not available, the GI was estimated according to van Bakel et al (20) . The same GI value was assigned to any given food every time it was reported. The GI for each food item was multiplied by the proportion of total carbohydrate contributed by the food to obtain a weighted GI. The daily GI was calculated by summing the weighted values for each food item for that day.
Participants in both groups were informed of the benefits of regular physical activity for weight management and insulin sensitivity and encouraged to do 30 min of moderate-intensity exercise most days aiming for 10,000 steps each day according to a pedometer.
Statistical treatment
The primary outcome (ISI OGTT ) and secondary outcomes are reported as means 6 SEMs for the subjects who completed the study. An intention-to-treat analysis in which the last data point was carried forward was applied to weight loss but not other outcomes. Nonnormally distributed data were log transformed. Two-tailed statistical analyses were performed with a commercially available software package (SPSS version 16.0; SPSS Inc, Chicago, IL) with statistical significance defined as P , 0.05. Baseline group differences were compared by the independent t test. Within-group changes were analyzed as different from baseline by the paired t test. Mean-change scores for the 2 diet groups were compared without adjustment by the independent t test and after adjustment for baseline, metformin use, and weight loss by using the general linear model analysis of variance (univariate ANOVA). One-factor ANOVA was used to compare changes in study variables between subjects taking metformin compared with subjects not taking metformin and between subjects who developed more regular menstrual cycles compared with subjects who did not developed more regular menstrual cycles. Chi-square analysis and Fisher's exact test were used to compare the proportion in each group who developed more regular menstrual cycles. Subjects with baseline insulin-60 (ie, serum insulin 60 min after a 75-g glucose load) above and below the median (81 lmol/L) were analyzed separately for changes in body composition according to dietary group by using univariate ANOVA. A power-based estimate of sample size indicated that 100 subjects (50 in each group) were required for the study to achieve a 90% statistical power to detect a 30% difference in insulin-sensitivity change between the 2 diet groups.
RESULTS
In total, 96 subjects were recruited (low GI = 50 subjects; conventional healthy = 46 subjects). Baseline characteristics, including the use of metformin (1000-1500 mg/d), were similar in both groups ( Table 2) . For various reasons including competing commitments and unplanned pregnancies (Figure 1 ), 21 subjects in the low-GI diet group and 26 in the conventional healthy diet group failed to complete the study protocol (P = 0.22). Compared with completers (n = 49), subjects who dropped out had a higher baseline BMI (36.2 compared with 32.8; P , 0.01) and a higher insulin resistance as assessed by HOMA (4.0 compared with 2.7; P , 0.01). Although a 7% weight loss was the goal in both diet groups, many subjects failed to reach this goal within 12 mo (41% failure in the low-GI group compared with 50% failure in the conventional healthy group; P = 0.38). In the intention-to-treat analysis (with the last value carried forward), weight loss was 3.2 6 0.5% (2.8 6 0.4 kg) in the low-GI group and 2.1 6 0.5% (2.0 6 0.5 kg) in the conventional healthy group; P = 0.2). Among completers, the mean weight loss was 5.2 6 0.6% (4.4 6 0.5 kg) in the low-GI group and 4.2 6 0.9% (4.0 6 0.7 kg) in the conventional healthy group (P = 0.2). Changes in body fat, fat mass, and ratio of fat mass to lean mass among completers were also similar ( Table 3) .
Among completers, the primary outcome, insulin sensitivity as measured by ISI OGTT, increased significantly in the low-GI diet group (2.2 6 0.7; P , 0.01) but not in the conventional healthy diet group (0.7 6 0.6; P = 0.2) ( Table 3 ). The effect of diet composition was significant before and after adjustment for baseline differences, metformin use, and weight loss (P = 0.03). However, there was no effect of diet composition on insulin resistance as calculated by HOMA1 or HOMA2 (P = 0.86 and P = 0.83, respectively) or insulin sensitivity as calculated by HOMA2 %S (P = 0.27). Similarly, changes in b cell function as calculated by HOMA2-%B were not significantly different (P = 0.40, Table 3 ). There was no effect of diet composition on plasma lipid changes (Table 3) . Diet had a significant effect on hemostasis. Fibrinogen concentrations fell in the low-GI diet group (20.2 6 0.1 g/L) but increased in the conventional group (0.2 6 0.1 g/L) with significant effects before and after adjustment for baseline, weight loss, and metformin use (P = 0.05). Changes in PAI-1, CRP, testosterone, and sex hormone-binding globulin concentrations and the free androgen index were not significant after adjustment for baseline, weight loss, and metformin use (Table 3) .
Similarly, changes in luteinizing hormone and folliclestimulating hormone concentrations were not significantly different between groups (Table 3) .
Diet composition had significant effects on menstrual cyclicity. Among the completers who had irregular cycles at baseline (76%, n = 37), a greater proportion of the low-GI group showed an increase in menstrual regularity compared with the proportion of subjects in the conventional group (95% compared with 63%; P = 0.03). Dietary GI was lower in subjects who became regular than in subjects who did not (23.7 6 0.8 compared with 20.4 6 0.8, respectively; P = 0.01) but changes in energy, macronutrients, dietary fiber, and dietary GL did not differ. Both diets were associated with improved quality of life as measured by domain scores on the Polycystic Ovary Syndrome Questionnaire (Figure 2) . The domain score for emotions was the only one that LGI, low glycemic index; CHD, conventional healthy diet; LBM, lean body mass; FM, fat mass; LDL-C, LDL cholesterol; HDL-C, HDL cholesterol; Tx, treatment; SHBG, sex hormone-binding globulin; FAI, free androgen index; LH, luteinizing hormone; FSH, follicle-stimulating hormone; HOMA1-IR, original homeostatic model assessment of insulin resistance; HOMA2-IR, updated HOMA nonlinear computer model of insulin resistance; HOMA2-%IS, HOMA2 of insulin sensitivity; HOMA2-%b; HOMA2 of percentage b cell function; ISI OGTT , insulin sensitivity index derived from the oralglucose-tolerance test according to Matsuda and DeFronzo (15) ; CRP, C-reactive protein; PAI-1, plasminogen activator inhibitor 1. To convert glucose to milligrams per deciliter, multiply by 18; to convert insulin values to microunits per milliliter, divide by 6.945.
2 Between-group differences analyzed by independent t test. showed a significant effect of diet composition, with higher scores in the low-GI group (P = 0.05).
Dietary adherence and physical activity
Analysis of food diaries showed the target macronutrient distribution was mostly achieved with no significant differences between groups ( Table 4) . Dietary fiber intake was below the target in both groups although not significantly different. Dietary GI was significantly higher in the conventional group (57 6 1) than in the low-GI group (51 6 1, P = 0.001), although the latter did not achieve the target level (Table 4 ). There were no differences in intakes of saturated, monounsaturated, or polyunsaturated fats at baseline or the study end between the 2 groups (data not shown).
Analysis of daily step counts from pedometer readings showed no significant difference between the groups at baseline or during the study (9090 6 490 compared with 8830 6 410 steps at baseline and 10340 6 650 compared with 9520 6 620 steps during the study in the low-GI and conventional groups, respectively).
Metformin-diet interactions
A significant interaction was shown between metformin use and diet group on the primary outcome, ISI OGTT (P = 0.048). 1 All values are means 6 SEMs for the 49 subjects who completed the study.
LGI, low glycemic index; CHD, conventional healthy diet; WL, weight loss; FM, fat mass; LBM, lean body mass; ISI OGTT , insulin sensitivity index derived from the oral-glucose-tolerance test according to Matsuda and DeFronzo (15) ; HOMA1-IR, original homeostatic model assessment of insulin resistance; HOMA2-IR, updated HOMA nonlinear computer model of insulin resistance; HOMA2-%IS, HOMA2 of insulin sensitivity; HOMA2-%b, HOMA2 of percentage b cell function; CRP, C-reactive protein; PAI-1, plasminogen activator inhibitor 1; TC, total cholesterol; TG, triglycerides; test, testosterone; SHBG, sex hormone-binding globulin; FAI, free androgen index; LH, luteinizing hormone; FSH, follicle-stimulating hormone. To convert glucose to milligrams per deciliter, multiply by 18; to convert insulin values to microunits per milliliter, divide by 6.945.
2 Unadjusted (independent t test). 3 Adjusted for baseline (weight and body fat) or baseline and metformin (other variables) by using the general linear model ANOVA (univariate ANOVA). 4 Adjusted for baseline, metformin, and weight loss by using the general linear model ANOVA (univariate ANOVA).
Subjects on the low-GI diet who were prescribed metformin achieved greater improvements in insulin sensitivity than subjects on the low-GI diet who were not prescribed metformin (4.3 6 1.0 compared with 1.1 6 0.7, respectively; P = 012 for pairwise comparison), whereas subjects on the conventional diet who were taking metformin had less improvement in insulin sensitivity than subjects on the conventional diet who were not taking metformin (0.2 6 1.1 compared with 1.0 6 1.0, respectively; P = 0.62). This interaction was not significant for other variables. Irrespective of diet group, there were no significant differences between metformin users and nonusers regarding changes in weight loss, body composition, plasma lipid concentrations, or reproductive hormone concentrations (data not shown). Weight loss, metformin use, or the combination of these was not shown to predict changes in menstrual cycle regularity.
High insulin secretion-diet interactions
There were no significant interactions between postprandial insulin secretion at the start of the study (ie, high or low 60-min insulin response in OGTT) and diet group on any of the primary or secondary outcomes. Although the study was not powered for this purpose, high-insulin secretors (ie, above the median) in the low-GI group seemed to show a 2-fold greater reduction in body fat than did those in the conventional group (2.2 6 0.6 compared with 1.1 6 0.4; P = 0.34). There were no trends among the lowinsulin secretors.
DISCUSSION
The findings of this study indicate that the capacity of dietary carbohydrates to increase postprandial glycemia may be an important consideration for optimizing metabolic and clinical outcomes in PCOS. Independently of the degree of weight loss, an ad libitum low-GI diet had benefits over and above the benefits of a conventional low-fat diet that was matched closely for macronutrient and fiber content. With only modest weight loss (4-5% of body weight), the low-GI diet provided a 3-fold greater improvement in whole-body insulin sensitivity (ISI OGTT ) as calculated from responses to a 75-g oral glucose challenge and greater improvement in hemostasis as judged by changes in serum fibrinogen. Clinically, compared with the proportion of subjects on the conventional diet, a larger proportion of subjects on the low-GI diet reported improved menstrual regularity (95% compared with 63%, respectively) and better emotion scores on a questionnaire designed to detect changes in quality of life. By contrast, both the low-GI and the conventional diets led to similar improvements or changes in blood lipid and androgenic hormones concentrations, markers of inflammation, and other measures of quality of life. To the best of our knowledge, the current study provides the first clinical evidence to justify the use of low-GI diets in the management of PCOS.
Our findings are consistent with studies in other population groups in which low-GI diets enhanced insulin sensitivity, as measured by a variety of methods in a range of subjects, including individuals with type 2 diabetes and/or who were overweight (21) (22) (23) (24) (25) (26) , and animal models. Because intrinsic insulin resistance underlies the development of PCOS, the mechanism by which a low-GI diet exerts its effect is likely to be via improvements in glucose homeostasis that stem from reductions in postprandial glycemia and insulinemia. However, the choice of methodology for measuring insulin sensitivity appears to influence outcomes. In the current study, measures of insulin resistance in the fasting state 3 Actual values (means 6 SEMs) were calculated from food diaries completed during the intervention. 4 For comparison of actual values between the 2 diets (independent t test).
(HOMA1 and HOMA2), which mainly reflect hepatic-glucose production, were similar on both diets. In contrast, ISI OGTT , a composite of both hepatic and peripheral glucose metabolism, differed significantly. ISI OGTT correlates strongly (r = 0.73, P , 0.0001, n = 153) with the measures of insulin sensitivity derived from the euglycemic insulin clamp and was proposed to be a better measure of whole-body insulin sensitivity than HOMA (15) , particularly in the PCOS population (27) . Some studies reported that subjects with a high postprandial insulin response (above the median at 30 min during an OGTT) were more successful at losing weight on a low-GL than on a low-fat diet (9) (10) (11) . Similarly, we observed a nonsignificant trend for subjects with higher 60-min insulin concentration to lose more body fat on the low-GI diet than on the conventional healthy diet (P = 0.34), which was absent in those with low insulin secretion. Thus, further studies with adequate power are needed to explore the hypothesis that insulin secretion is an important determinant of success on low-GI or low-GL diets in women with PCOS.
Diet composition may also influence risk factors of cardiovascular disease, which is a major concern in women with PCOS. In individuals with overweight and/or type 2 diabetes, greater reductions in PAI-1 and CRP concentrations were observed on a low-GI diet than on a high-GI or higher-GL diet (25, (28) (29) (30) (31) (32) . Like some of those studies, we observed that fibrinogen concentrations, and to a lesser extent PAI-1 concentrations, actually increased on a conventional healthy diet, even in the midst of weight loss. This observation deserves further investigation because conventional advice in this patient population frequently takes the form of asking patients to choose whole grains or eat high-fiber, low-fat foods. However, it is clear that whole-grain foods come in both high-and low-GI versions (33) . Women with PCOS have a greater risk of cardiovascular disease than women of the same age without the condition (34) , and women with PCOS may be particularly susceptible to the harmful effects of postprandial glucose increases on hemostasis (35, 36) .
Many studies have shown the benefits of weight loss and lifestyle changes in improving menstrual regularity (37) (38) (39) . Of subjects who completed the current study and had irregular cycles before the study commencement, almost all subjects on the low-GI diet showed improved menstrual cyclicity compared with the menstrual cyclicity of two-thirds of subjects on the conventional healthy diet. Furthermore, the change in dietary GI was significantly greater in subjects who became more regular than in subjects who did not became more regular (P = 0.01). The mechanism underlying the improvements in menstrual cycle regularity and ovulation is believed to be via improvements in insulin sensitivity (37, 40) .
We did not find significant effects of dietary composition on plasma lipid concentrations, which is a result that may be attributed to the fact that most subjects had plasma lipid concentrations within the normal range at baseline. There was also no difference between the 2 dietary groups for any of the hormonal variables, which is a finding that is also consistent with previous dietary studies in our population (37, 41) .
Metformin, an insulin-sensitizing agent that is commonly prescribed for women with PCOS, was shown to improve both metabolic and reproductive variables (42) (43) (44) . However, it is not clear if metformin use has benefits over and above dietary and lifestyle change (41, (45) (46) (47) (48) . In the current study, insulin sensitivity and secondary outcomes were similar in subjects with and without metformin use, irrespective of diet composition. Interestingly, there was a significant interaction between diet and metformin use such that the combination of a low-GI diet + metformin use was associated with the greatest improvements in insulin sensitivity. This observation may indicate that the mechanisms differ and may have been additive, but the small number of subjects indicates the need for further study.
This study has a number of strengths but also limitations. The study was adequately powered to detect changes in the primary outcome although not all the secondary outcomes, including changes in PAI-1. In the study design, controlling for weight loss allowed the effect of dietary composition to be examined independently of weight loss. By comparing a low-GI diet to a healthy diet with a similar fiber content, we were also able to study the effects of GI per se, independent of differences in dietary fiber and carbohydrate intakes, which were similar in both groups. An important limitation of other studies comparing highand low-GI diets in other conditions is the lack of reliable GI data for local foods. Thus, the detailed knowledge of the GI of Australian foods tested according to standardized methods is a strength of the current study. Dietary compliance was maximized by regular consultations with a dietitian and the provision of detailed food instructions, menu plans, shopping lists, and sample foods. The use of dietary counseling in free-living subjects who consumed ad libitum diets means the findings can be extrapolated to nutritional management of PCOS in routine clinical practice. However, the high dropout rate, and the observation that dropouts were significantly heavier and more insulin resistant, indicates that the most severe forms of PCOS may not be amenable to ad libitum dietary interventions. Other studies in women with PCOS of a 16-wk duration have shown similarly high dropout rates (range: 35-54%) (37, 38, 41, 49) . Many subjects failed to achieve the intended 7% weight loss, which corroborated the view that women with PCOS, like individuals with type 2 diabetes, find weight loss particularly difficult. There was a potential for bias to arise because the subjects were assigned alternately to one or the other diet rather than by computer randomization. The research dietitian was not blinded to group assignment, although bias was minimized by maintaining a similar treatment intensity between the groups. Finally, the difference in dietary GI achieved between the 2 groups was smaller than anticipated and yet sufficient to achieve differences in the primary outcome.
In conclusion, an ad libitum, low-GI diet with or without metformin therapy may provide an additional advantage over and above that of a conventional healthy diet in managing the underlying insulin resistance, cardiovascular risk, and irregular menstrual patterns in women with PCOS who are overweight but not morbidly obese. Our findings contribute to a greater understanding of the difficulties of weight loss in this population group and the need for future studies that address the high attrition rate and the role of high compared with lower postprandial insulin secretion (assessed by 30-60-min insulin concentrations on OGTT) in glucose homeostasis and weight control.
The authors' responsibilities were as follows-KAM and JCB-M: conceived and designed the study and contributed to the statistical analyses, interpretation, and writing of the manuscript; KAM and PP: had full access to all data and were responsible for the accuracy of data analysis; KSS: contributed to the study design, data interpretation, and writing of the manuscript; and FSA: conducted dual-energy X-ray absorptiometry scans and assisted with data collection and interpretation. The funding organizations did not participate in the study design; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the article for publication. JBC-M is a co-author of The New Glucose Revolution book series (Hodder & Stoughton, London, United Kingdom; Marlowe & Co and Hodder Headline, Sydney, Australia, and elsewhere). KAM and JCB-M are co-authors of The Low GI Guide to Managing PCOS (Hachette Australia, Sydney, Australia, 2006). FSA is employed by the Sydney University GI Research Service for the purposes of GI testing. KSS and PP had no conflicts of interest to declare.
